secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oncology Institute, Inc. (TOI)
CIK:        0001799191
Form:       8-K
Filed at:   2024-11-12T23:59:59+00:00
Accession:  0001079973-24-001491
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Director Maeve O'Meara resigns effective Jan 1, 2025; Gabriel Ling to become independent director
--------------------------------------------------------------------------------

- Maeve O'Meara notified board of her resignation as director for personal reasons, effective January 1, 2025.
- Resignation is not the result of any disagreement with the company, board, or operations.
- Board determined that existing director Gabriel Ling will qualify as independent as of the Effective Date.
- After the departure, a majority of independent directors will remain on the board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799191/000107997324001491/0001079973-24-001491-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799191/000107997324001491/toi_8k.htm
  HTML page:      https://secwatch.observer/filing/0001079973-24-001491

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer